5 Minutes Read
Coronavirus vaccine: ICMR fast-tracks COVAXIN procedure, aims at August 15 launch
KV Prasad Jun 13, 2022, 06:35 AM IST (Published)
Listen to the Article (6 Minutes)
Summary
The Indian Council of Medical Research has written to clinical trial sites to fast track all approvals and initiate enrolment for clinical trials of the indigenous COVID-19 vaccine, Covaxin, by July 7, so that “results of the clinical trials can be launched by August 15.” ICMR and Bharat Biotech International Limited are jointly working for …
Continue reading “Coronavirus vaccine: ICMR fast-tracks COVAXIN procedure, aims at August 15 launch”
The Indian Council of Medical Research has written to clinical trial sites to fast track all approvals and initiate enrolment for clinical trials of the indigenous COVID-19 vaccine, Covaxin, by July 7, so that “results of the clinical trials can be launched by August 15.”
ICMR and Bharat Biotech International Limited are jointly working for the preclinical as well as clinical development of the vaccine.
ICMR has written to all clinical trial partners to fast track the enrollment process.
“It is envisaged to launch the vaccine for public use latest by August 15 after completion of all clinical trials. BBIL is working expeditiously to meet the target however the final outcome will depend on the cooperation of all clinical sites involved in this project,” the ICMR letter said, adding that non-compliance would be “viewed seriously.”
ICMR and Bharat Biotech declined to comment on the letter.
Elon Musk forms several ‘X Holdings’ companies to fund potential Twitter buyout
3 Mins Read
Thursday’s filing dispelled some doubts, though Musk still has work to do. He and his advisers will spend the coming days vetting potential investors for the equity portion of his offer, according to people familiar with the matter
Daily Newsletter
